USA - NASDAQ:DHC - US25525P1075 - REIT
ChartMill assigns a Buy % Consensus number of 48% to DHC. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-13 | RBC Capital | Upgrade | Underperform -> Sector Perform |
| 2025-09-17 | B. Riley Securities | Maintains | Buy -> Buy |
| 2024-10-14 | RBC Capital | Maintains | Underperform -> Underperform |
| 2024-08-21 | JMP Securities | Reiterate | Market Perform |
| 2024-08-05 | B. Riley Securities | Maintains | Buy -> Buy |
| 2023-09-05 | B. Riley Securities | Maintains | Buy -> Buy |
| 2021-12-30 | B. Riley Securities | Maintains | Buy |
| 2021-07-29 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-03-15 | Morgan Stanley | Maintains | Equal-Weight |
10 analysts have analysed DHC and the average price target is 4.34 USD. This implies a price decrease of -3.88% is expected in the next year compared to the current price of 4.51.
The consensus rating for DIVERSIFIED HEALTHCARE TRUST (DHC) is 48 / 100 . This indicates that analysts generally have a neutral outlook on the stock.